Onxeo S.A. | Key People and Executives
Judith Greciet
Chief Executive Officer & Director
Joseph S. Zakrzewski
Non-Executive Chairman
Jean-Pierre Kinet
Independent Director
Jean-Pierre Bizzari
Independent Director
Danièle Guyot-Caparros
Senior Independent Director
Jean Nicolas Trebouta
Independent Director
Thomas Hofstaetter
Independent Director
Judith Greciet
Chief Executive Officer & Director
Nicolas Fellmann
Chief Financial Officer & Secretary
Olivier de Beaumont
Chief Medical Officer
Françoise Bono
Chief Scientific Officer
Audrey Legentil-Duméry
Director-Human Resources
Joseph S. Zakrzewski
Non-Executive Chairman
Elvira Sanz
Independent Director
Christine Garnier
Independent Director
Jean-Pierre Kinet
Independent Director
Jean-Pierre Bizzari
Independent Director
Danièle Guyot-Caparros
Senior Independent Director
Jean Nicolas Trebouta
Independent Director
Thomas Hofstaetter
Independent Director
| Address |
49, blvd. du Général Martial Valin
Paris Ile-de-France 75015
France
|
|
Employees
|
- |
| Website |
http://www.onxeo.com |
| Updated |
07/08/2019 |
| Onxeo SA is a biotechnology company, which engages in the development of drugs for the treatment of orphan diseases. It produces and develops ophan oncology products under the brand names Livatag, Validive, Beleodaq and AsiDNA. The company was founded by Gilles Avenard and Dominique Costantini on March 5, 1997 and is headquartered in Paris, France. |
